US19459J1043
US19459J1043
Collegium Pharmaceutical, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 780.567.000 | 631.449.000 | 23.6% |
| Cost of Revenue | 317.310.000 | 254.105.000 | 24.9% |
| Gross Profit | 463.257.000 | 377.344.000 | 22.8% |
| 284.803.000 | 210.363.000 | 35.4% | |
| Operating Income | 178.454.000 | 166.981.000 | 6.9% |
| Pretax Income | 92.619.000 | 98.568.000 | 6.0% |
| Net Income Common Stockholders | 62.870.000 | 69.190.000 | 9.1% |
| -- | -- | -- | |
| -- | -- | -- |